STERIS stock after-hours at EUR 189.30: plus 2.16 percent versus prior close
STERIS stock traded at EUR 189.30 after-hours on October 5, 2026, marking a 2.16 percent increase from its prior close of EUR 185.30. This rise follows an announcement on September 29, 2026, that STERIS plc plans to invest $600 million in a new manufacturing and distribution center in North Carolina, creating 335 jobs.
As 783 shares vest, STERIS (STE) CFO has 228 shares withheld for taxes.
STERIS plc CFO Karen L. Burton had 228 ordinary shares withheld for taxes from a vesting of 783 restricted ordinary shares on October 1, 2026. Following this transaction, she directly holds 12,956 ordinary shares, with an additional 8,499 ordinary shares remaining restricted as of October 2, 2026. The original 783 shares were awarded to Ms. Burton on October 1, 2025.
STERIS stock gets a strong-buy upgrade after 7.3 percent growth
STERIS stock (STE) received a "Strong Buy" upgrade from Wall Street Zen on October 3, 2026, pushing its average analyst target to USD 271.33, 30.1% above its October 2nd closing price of USD 208.54. This upgrade follows a solid fiscal 2027 first-quarter performance, where the company reported a 7.3% revenue increase to USD 1.49 billion and an adjusted EPS of USD 2.59, exceeding consensus estimates. Despite positive guidance and strong revenue growth, the stock remains below its 52-week high.
Steris plc stock trades 0.00 percent from its Xetra close of EUR 185.30 in weekend trading
Steris plc stock traded at EUR 185.30 in weekend trading on October 4, 2026, showing no change from its Xetra close of EUR 185.30. This price stability was observed at Lang & Schwarz as of 5:48 p.m. CEST, matching the previous close from October 2, 2026. The next Xetra session is scheduled for October 5, 2026.
STERIS stock reports 7.3 percent revenue growth as guidance holds
STERIS (ISIN IE00BFY8C754) reported a 7.3% year-over-year revenue growth to $1.49 billion and an adjusted EPS of $2.59 for fiscal Q1 2027, exceeding consensus estimates for earnings but missing slightly on revenue. The company reaffirmed its fiscal 2027 adjusted EPS guidance of $11.10-$11.30 and revenue growth guidance of 7-8%. Despite a recent upgrade to "strong-buy" by Wall Street Zen and analyst targets significantly above its current trading price, the stock remains below its 52-week high, presenting a mixed picture for investors focused on both operational growth and share performance.
Steris stock trades at EUR 185.30 against its EUR 185.30 Xetra close in weekend trading
Steris stock is trading at EUR 185.30 in weekend trading, matching its last Xetra close. The stock price remained unchanged at Lang & Schwarz on October 3, 2026, compared to the previous Xetra trading day. The next Xetra session for Steris plc is scheduled for October 5, 2026.
STERIS (NYSE:STE) Raised to Strong-Buy at Wall Street Zen
Wall Street Zen has upgraded STERIS (NYSE:STE) from a "buy" to a "strong-buy" rating. This upgrade aligns with an overall "Moderate Buy" analyst sentiment and an average price target of $271.33 for the medical equipment provider. STERIS recently reported strong quarterly earnings, beating EPS estimates by $0.10 and achieving a 7.3% year-over-year revenue increase.
STERIS stock after-hours at EUR 184.65: minus 0.83 percent versus prior close
STERIS stock closed after-hours at EUR 184.65 on October 2, 2026, marking a 0.83 percent decrease from its prior close. Trading in Germany at Lang & Schwarz reported a prior close of EUR 186.20 on October 1, 2026, with current bids at EUR 182.70 and asks at EUR 186.60. The article details the real-time after-hours trading performance of STERIS stock.
Steris plc stock trades 0.40 percent above its prior close
Steris plc (ISIN IE00BFY8C754) saw its stock trade 0.40 percent higher at EUR 186.95 on October 2, 2026, compared to its previous close of EUR 186.20. The company reported a 7.30 percent increase in first-quarter fiscal 2027 revenue to USD 1.49 billion, with adjusted earnings per share rising 10.68 percent to USD 2.59, exceeding consensus estimates. Analysts maintain a "Moderate Buy" consensus with an average target of USD 271.33, and the company recently increased its quarterly dividend by 9.52 percent.
STERIS (STE) Dividend Yield 2026, Date & History $STE
This article provides a detailed overview of STERIS (STE) dividend information for 2026, including its dividend yield, annual dividend, and payment history. STERIS pays quarterly dividends, has increased its dividend for 20 consecutive years, and maintains a healthy payout ratio. The report also compares STERIS's dividend performance against healthcare and NYSE averages and addresses frequently asked questions about its dividend.
STERIS stock after-hours at EUR 186.35: plus 0.54 percent versus prior close
STERIS stock traded at EUR 186.35 after-hours on October 1, 2026, marking a 0.54 percent increase from its previous close of EUR 185.35 at Lang & Schwarz. The company had previously announced its participation in the Morgan Stanley Healthcare Conference in September, where its CEO was scheduled to present. This after-hours performance indicates a slight positive movement for the stock.
ADSEW - ADS-TEC ENERGY PLC Warrant stock news, filings & ratings
This article provides an overview of ADS-TEC ENERGY PLC Warrant (ADSEW), a B2B technology company specializing in intelligent battery buffered energy systems. It details the company's products, stock performance, recent SEC filings, and relevant news, highlighting its market position within the Industrial Specialties industry.
Total equity of STERIS plc – HAN:2TG
This article provides financial information for STERIS plc (HAN:2TG) on the Hannover Stock Exchange, specifically focusing on its total equity. It notes that the market is closed with no trades. The content is primarily a listing of navigation links and disclaimers rather than a detailed financial report.
Operating expenses (excl. COGS) of STERIS plc – HAN:2TG
This article provides financial data for STERIS plc (HAN:2TG) on the Hannover Stock Exchange, specifically focusing on its operating expenses excluding the Cost of Goods Sold (COGS). It presents a high-level overview of the company's financials without detailed figures, indicating the period, value, and percentage change. The content appears to be a stub or a section of a larger financial data page on TradingView.
Return on invested capital % of STERIS plc – HAN:2TG
The article focuses on the "Return on invested capital %" for STERIS plc (HAN:2TG), traded on the Hannover Stock Exchange. It provides a snapshot of the company's financial data as presented on TradingView. The page indicates that the market is currently closed with no trades.
Total assets of STERIS plc – HAN:2TG
This page provides financial data for STERIS plc (HAN:2TG) on the Hannover Stock Exchange, specifically focusing on its total assets. The content displays the company's ticker, exchange, and market status, indicating no recent trades. It appears to be a section of a larger financial data platform.
Cost of goods sold of STERIS plc – HAN:2TG
This article from TradingView provides financial information for STERIS plc (HAN:2TG) listed on the Hannover Stock Exchange. It specifically presents the "Cost of goods sold" data for the company, indicating that this financial metric was "Made by humans" and noting that market data is provided by ICE Data Services and FactSet.
STERIS plc Dividends – HAN:2TG
This article provides dividend information for STERIS plc (HAN:2TG) on the Hannover Stock Exchange. It states that dividend payouts are made quarterly, with the last dividend per share being 0.59 EUR. As of the article's publication, the trailing twelve months (TTM) dividend yield is 1.19%.
STERIS plc Bonds — Corporate Bond Rates
This article provides a list of STERIS plc corporate bonds, sorted by yield to worst, noting their stability for investors during market volatility. It includes key financial details such as yield, price, coupon rate, maturity date, outstanding amount, face value, and S&P/Fitch credit ratings for two specific bonds issued by STERIS Irish FinCo ULC.
Rep. Kevin Hern Unloads Shares of Honeywell International Inc. (NASDAQ:HON)
Representative Kevin Hern recently sold shares of Honeywell International Inc. (NASDAQ:HON) valued between $15,001 and $50,000 on August 31st through the Hern Family Foundation account, alongside sales of several other stocks in mid-September. Honeywell shares opened down 0.5% at $211.52, trading below their 50-day and 200-day moving averages, despite the company recently beating earnings estimates and announcing a $0.70 quarterly dividend. Analyst sentiment on HON is mixed, with a consensus "Hold" rating and an average price target of $251.88.
Rep. Kevin Hern Sells Shares of ONEOK, Inc. (NYSE:OKE)
Representative Kevin Hern (R-Oklahoma) recently sold between $50,001 and $100,000 worth of ONEOK, Inc. (NYSE:OKE) shares on August 31st through his family foundation. The article details ONEOK's financial performance, including its recent quarterly earnings that beat estimates, its dividend, and institutional ownership. It also includes analyst ratings and other stock sales made by Rep. Hern, such as CenterPoint Energy and NextEra Energy.
TJX Companies (NYSE:TJX) Shares Sold by Rep. Kevin Hern
Rep. Kevin Hern sold shares of TJX Companies (NYSE:TJX) from the HERN FAMILY FOUNDATION account on August 31, valued between $15,001 and $50,000, and again on September 15 for $1,001–$15,000. Despite recent analyst downgrades to "Hold," TJX beat quarterly earnings and revenue expectations with $1.22 EPS and $15.18 billion in revenue, and declared a quarterly dividend of $0.48 per share. The company currently holds a consensus "Moderate Buy" rating with an average price target of $171.63.
Rockwell Automation (NYSE:ROK) Stock Sale Reported by Rep. Kevin Hern
Rep. Kevin Hern sold between $15,001 and $50,000 worth of Rockwell Automation shares on September 14, 2026, through his family foundation, alongside sales of several other stocks. Despite the stock trading down 0.5% at $431.86, Rockwell Automation reported strong quarterly earnings and revenue, exceeding analyst expectations, and authorized a $1 billion stock buyback. The company holds a mixed outlook from analysts, with institutional investors owning a significant portion of shares.
Marsh & McLennan Companies (NYSE:MRSH) Shares Sold Off by Rep. Kevin Hern
Representative Kevin Hern recently sold shares of Marsh & McLennan Companies (NYSE: MRSH) from his family's revocable trust on two separate occasions in September. The company's stock opened at $168.97, below its 50-day moving average, and reported strong quarterly earnings, beating analyst estimates. Despite these sales, the consensus analyst rating for Marsh & McLennan Companies remains "Hold" with an average price target of $203.50.
Emerson Electric (NYSE:EMR) Stock Sale Revealed by Rep. Kevin Hern
Representative Kevin Hern of Oklahoma sold between $15,001 and $50,000 worth of Emerson Electric (NYSE: EMR) shares on September 14th through his family foundation account. This sale was part of several other stock transactions made by Hern around the same time. Despite the sale, Emerson Electric recently reported strong quarterly earnings, beating analyst estimates, and maintains a "Moderate Buy" consensus rating from analysts with an average price target of $169.65.
Rep. Kevin Hern Sells Shares of The Home Depot, Inc. (NYSE:HD)
Rep. Kevin Hern recently sold shares of The Home Depot (NYSE: HD) worth between $15,001 and $50,000 from his family foundation account on September 14, 2026. This comes as Home Depot reported stronger-than-expected quarterly results, including EPS of $4.92 and revenue of $47.86 billion, with the company also offering a 3.2% annualized dividend yield. Despite positive earnings and a "Moderate Buy" analyst consensus, the stock is trading near its 52-week low, with higher mortgage rates and weak housing turnover posing significant risks.
Devon Energy (NYSE:DVN) Stock Sale Reported by Rep. Kevin Hern
Rep. Kevin Hern sold shares of Devon Energy (NYSE:DVN) worth $15,001–$50,000 on September 14, 2026, through his family foundation, as part of broader sales in various companies. This comes amidst strong quarterly results for Devon Energy, which reported EPS of $1.57, revenue up 73.1% year-over-year, and a quarterly dividend of $0.32 per share. Despite the congressional sale, analyst sentiment remains a "Moderate Buy" with a $59.72 price target, and institutional ownership stands at 69.72%.
Rep. Kevin Hern Sells Shares of Colgate-Palmolive Company (NYSE:CL)
Representative Kevin Hern (Republican-Oklahoma) recently sold between $1,001 and $15,000 worth of Colgate-Palmolive (NYSE: CL) stock on September 2nd through his family trust, as disclosed on September 25th. He also reported selling shares in several other companies earlier in September. Colgate-Palmolive reported strong quarterly earnings, beating estimates with $0.99 EPS and a 4.9% revenue increase to $5.36 billion, and declared a quarterly dividend of $0.53 per share.
Rep. Kevin Hern Unloads Shares of STERIS plc (NYSE:STE)
Rep. Kevin Hern sold between $15,001 and $50,000 worth of STERIS plc (NYSE:STE) shares from his traditional IRA on September 15, 2026, alongside other stock sales. STERIS recently reported strong quarterly earnings, beating estimates with $2.59 EPS and 7.3% revenue growth, and raised its quarterly dividend. Analysts maintain a "Moderate Buy" rating with a consensus price target of $271.33.
Apple (NASDAQ:AAPL) Stock Unloaded by Rep. Kevin Hern
Representative Kevin Hern sold shares of Apple stock, valued between $1,001 and $15,000, from his trust account on September 8th, alongside other stock sales. This occurred while Apple reported strong quarterly earnings exceeding analyst estimates and its stock traded near a 52-week high, maintaining a "Moderate Buy" consensus rating from analysts. The company faces both positive developments, such as new chip investments and a Qualcomm patent agreement, and potential legal risks from a large patent award and revived regulatory cases.
TJX Companies (NYSE:TJX) Stock Sold Off by Rep. Kevin Hern
Representative Kevin Hern recently sold shares of TJX Companies (NYSE:TJX) on two separate occasions in September, through his family foundation. Despite these sales, TJX Companies reported strong quarterly earnings, beating analyst estimates with a 5.4% year-over-year revenue increase and a $1.22 EPS. Analysts maintain a "Moderate Buy" rating with a consensus price target of $171.63, and the company also declared a quarterly dividend of $0.48 per share.
Rep. Kevin Hern Sells Shares of Cadence Design Systems, Inc. (NASDAQ:CDNS)
Representative Kevin Hern of Oklahoma recently sold shares of Cadence Design Systems (NASDAQ: CDNS) valued between $15,001 and $50,000 on September 2nd, as disclosed in a September 25th filing. This sale, made through the Hern Family Foundation account, is part of broader recent divestments by the Representative, including shares in CenterPoint Energy, STERIS, Home Depot, and NextEra Energy. Cadence Design Systems reported strong quarterly earnings, exceeding analyst expectations, and maintains a "Moderate Buy" consensus rating from analysts with an average price target significantly above its recent share price.
Linde (NASDAQ:LIN) Stock Unloaded by Rep. Kevin Hern
Representative Kevin Hern recently sold between $15,001 and $50,000 worth of Linde (NASDAQ:LIN) stock from his family foundation account, alongside other stock sales in September. This occurred after Linde reported strong quarterly earnings of $4.50 EPS and $9.29 billion in revenue, exceeding analyst estimates. Despite the sale, analysts maintain a consensus "Buy" rating for Linde with an average price target of $544.60, and institutional investors hold a significant 82.8% of the company's stock.
STERIS stock at USD 209.34 on September 28, 2026
STERIS plc stock closed at USD 209.34 on the NYSE on September 28, 2026, marking a 0.20 percent increase from its prior close. This update follows the company's announcement on September 1, 2026, regarding its participation in the Morgan Stanley Healthcare Conference where President and CEO Dan Carestio was scheduled to present. The company made webcasts and replays available via its investor relations website.
Healthcare Equipment and Supplies Stocks Q2 Highlights: GE HealthCare (NASDAQ:GEHC)
This article reviews the Q2 performance of several healthcare equipment and supplies stocks, highlighting GE HealthCare (GEHC), Baxter (BAX), LeMaitre (LMAT), STERIS (STE), and Lantheus (LNTH). It details their revenue performance against analyst expectations and stock price movements, noting GE HealthCare's satisfactory quarter with increased orders, Baxter's strong revenue beat, LeMaitre's disappointing results and guidance, STERIS's mixed quarter, and Lantheus's impressive revenue and EPS beat. The sector as a whole saw a decline in share prices despite revenues generally beating estimates.
STERIS stock last at USD 208.44, down 0.16 percent in New York trading
STERIS stock closed at USD 208.44, down 0.16 percent, underperforming the S&P 500 which gained 0.53 percent. The company recently announced a USD 600 million investment in a North Carolina manufacturing and distribution campus, while Argus lowered its price target for STERIS to USD 240.00. The stock lagged behind healthcare peers like Abbott Laboratories and Stryker during the session.
STERIS stock trades lower before the bell after a 0.6 percent drop
STERIS stock experienced a 0.6 percent drop, closing at USD 209.97 on September 24, 2026, while the S&P 500 slipped less than 0.1 percent. The company is scheduled to pay a USD 0.69 quarterly dividend today, September 25, 2026. STERIS plc traded within a 52-week range of USD 195.14 to USD 269.44.
CONMED Corporation (CNMD) Stock forecasts
Argus has lowered its target price for CONMED Corporation (CNMD) to $48.00, citing the medical equipment company's focus on sports medicine and general surgeries. The current stock price for CNMD is $45.18. The report, published on September 23, 2026, provides a summary of the company's business activities.
STERIS plc (Ireland) (STE) Stock forecasts
Argus has lowered its target price for STERIS plc (Ireland) (STE) to $230.00. STERIS is a medical technology company specializing in sterilization services and infection prevention. The report was published on September 23, 2026.
Steris plc stock heads into the open after closing at USD 208.79
Steris plc stock closed at USD 208.79 on September 23, 2026, a 0.17 percent decrease from its prior close, while the S&P 500 fell by 0.8 percent. The stock's 52-week high is USD 263.13, placing it USD 54.34 below that peak, and it experienced a negative 0.17 percent five-day change as of September 23, 2026. US investors are entering the September 24, 2026 session following market pressures from higher Treasury yields, rising oil prices, and a strong economic report.
Steris plc stock holds near its yearly low
Steris plc stock is trading near its 52-week low at USD 205.04 as of September 18, 2026, significantly below its yearly high of USD 269.44. Despite this, a recent market report cited a consensus target price of USD 271.33, suggesting a potential upside for the medical technology company. The company's market capitalization stands at USD 18.2 billion.
Steris plc stock heads into the open after a 1.44 percent drop
Steris plc stock closed at USD 205.04 on September 18, 2026, marking a 1.44 percent drop from the previous session. This put the stock USD 9.90 above its 52-week low and USD 64.40 below its 52-week high. The market anticipates a higher dividend for Steris shares, with a consensus target price of USD 271.33.
Steris plc stock closes at USD 205.04 as dividend support builds
Steris plc (IE00BFY8C754) closed at USD 205.04 on September 18, 2026, 32.4 percent below its consensus target of USD 271.33, trading closer to its 52-week low of USD 195.14 than its high of USD 269.44. While dividend support offers income appeal, the significant gap to the analyst target implies future operating results must validate a higher valuation. The company operates in healthcare, applied sterilization technologies, and life sciences, with a market capitalization of USD 18.2 billion.
Steris plc stock heads into the open after a 1.44 percent drop
Steris plc stock closed at USD 205.04 on the NYSE on September 18, 2026, marking a 1.44% drop and placing it near the lower end of its 52-week range. Despite the price decline, the company's annualized dividend of USD 2.76 per share provided income support for investors. For the upcoming session on September 21, 2026, the stock's performance is expected to be driven by broader market sentiment and sector trends, as no company-specific events are scheduled.
STERIS plc $STE Shares Acquired by Corient Private Wealth LP
Corient Private Wealth LP significantly increased its stake in STERIS plc (NYSE:STE) by 109.7% in Q2, bringing its total holdings to 20,978 shares valued at $4.4 million. This move is part of broader institutional interest, with such investors owning 94.69% of the company. STERIS reported strong Q2 earnings, beating EPS estimates and seeing a 7.3% revenue increase, while also raising its quarterly dividend.
Steris PLC stock underperforms Friday when compared to competitors
Shares of Steris PLC (STE) fell 1.44% to $205.04 on Friday, marking its fourth consecutive day of losses. This occurred during a mixed trading session where the S&P 500 Index rose 0.17% and the Dow Jones Industrial Average declined 0.18%. The stock's performance indicates underperformance relative to key market indices and competitors.
ETFs Investing in STERIS plc Stocks
This article lists various ETFs that include STERIS plc stocks in their holdings. The ETFs are sorted by market value and provide details such as weight, issuer, management style, expense ratio, and AUM, offering insights for investors interested in exposure to STERIS plc through diversified funds.
Engineers Gate Manager LP Purchases Shares of 9,499 STERIS plc $STE
Engineers Gate Manager LP recently acquired 9,499 shares of STERIS plc (NYSE:STE) during the second quarter, valued at approximately $2 million. This purchase is part of a broader trend of institutional investors modifying their holdings in STERIS, with Goldman Sachs Group Inc. and Cerity Partners LLC also increasing their stakes. The article details STERIS's stock performance, recent earnings, analyst ratings, and a recent dividend increase.
National Pension Service Cuts Stock Holdings in STERIS plc $STE
National Pension Service significantly reduced its stake in STERIS plc by 83.8% in Q2, selling over 156,000 shares. Despite this, institutional investors collectively own 94.69% of the company, and analysts maintain a "Moderate Buy" rating with an average price target of $271.33. STERIS also reported strong Q2 earnings, exceeding EPS estimates, and increased its quarterly dividend.
Rep. April McClain Delaney Sells Off Shares of Markel Group Inc. (NYSE:MKL)
Representative April McClain Delaney (D-Maryland) recently sold shares of Markel Group Inc. (NYSE:MKL) valued between $100,001 and $250,000 on August 25th, according to a September 9th filing. This sale was part of a larger divestment that included holdings in several other companies like Wabtec, Viking, and Trimble. Markel Group shares opened down 0.3% at $1,780.27, while analysts currently maintain a consensus "Hold" rating with an average price target of $2,025.
